Neo-NTP-CRT for Locally Advanced ESCC

NCT05130684 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Nivolumab

Sponsor

National Taiwan University Hospital